Trial Profile
A Double-blind, Randomized, Placebo-controlled Phase 1/2 Study of the Safety, Pharmacokinetics, and Antiviral Activity of GS-9131 in Antiretroviral-Naive, HIV-1 Infected Subjects.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Jul 2011
Price :
$35
*
At a glance
- Drugs Rovafovir etalafenamide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 05 Jul 2011 New trial record